Mozart Therapeutics
7 known investors
Mozart Therapeutics develops protein therapeutics focused on immunology and oncology treatments. The company is founded on research from Stanford University scientists and is led by experienced biopharmaceutical industry executives.
BiotechMedical Devices
Founders & leadership
MD
Mark DavisScientific Co-Founder
KC
K. Christopher GarciaScientific Co-Founder
CK
Calvin KuoScientific Co-Founder
KF
Katie FanningPresident & Chief Executive Officer
Investors · 7
In the news
- Sell or Invest in Mozart Therapeutics Stock Pre-IPOnasdaqprivatemarket.com · 2025
- Mozart Therapeutics: $25 Million Closed To Develop Disease-Modifying Therapies For Autoimmune And Inflammatory Diseasespulse2.com · 2023
- Mozart Therapeutics Raises $25 Million in Expanded Series A Financing to Support Clinical Development of First-in-Class CD8 Treg Modulators for the Treatment of Autoimmune Diseases - BioSpacebiospace.com · 2023
- Mozart Therapeutics Raises $25 Million in Expanded Series A Financing to Support Clinical Development of First-in-Class CD8 Treg Modulators for the Treatment of Autoimmune Diseasesprnewswire.com · 2023
- Mozart Therapeutics Launches with $55 Million Series A Financing to Develop Disease Modifying Therapeutics for Autoimmune and Inflammatory Diseasesprnewswire.com · 2021